LKT Labs

Biochemicals for Life Science Research

I-BET151

I-BET151

Product ID I0516
Cas No. 1300031-49-5
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $71.70 In stock
5 mg $131.00 In stock
10 mg $192.60 In stock
25 mg $367.90 In stock
Bulk Quote

Quicklinks

Description

I-BET-151 is a BET bromodomain (BRD) inhibitor that inhibits BRD2, BRD3, and BRD4. I-BET-151 exhibits anticancer chemotherapeutic and anti-inflammatory activities. In vitro and in vivo, this compound induces apoptosis and inhibits cellular proliferation in various cancer models. I-BET-151 inhibits recruitment of the P-TEFb component of cyclin-dependent kinase 9 (CDK9) to chromatin, causing transcriptional regression of Myc. I-BET-151 also inhibits bacteria-induced inflammation and sepsis in animal models.

Product Info

Cas No.

1300031-49-5
Purity

≥98%
Formula

C23H21N5O3
Formula Wt.

415.44
IUPAC Name

7-(3,5-dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-pyridin-2-ylethyl]-3H-imidazo[4,5-c]quinolin-2-one
Synonym

GSK-1210151A, GSK1210151A
Solubility

Ethanol 27 mg/mL (64.99 mM) DMSO Insoluble Water Insoluble
Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

I0516 MSDS PDF
Info Sheet

I0516 Info Sheet PDF

References

Chaidos A, Caputo V, Gouvedenou K, et al. Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762. Blood. 2014 Jan 30;123(5):697-705. PMID: 24335499.

Seal J, Lamotte Y, Donche F, et al. Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A). Bioorg Med Chem Lett. 2012 Apr 15;22(8):2968-72. PMID: 22437115.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G7444

    GSK-1070916

    AurKB/C inhibitor.
    ≥98%
  • N1995

    Neurotensin, guinea pig

    Endogenous neuropeptide involved in hormone releas...
    ≥95%
  • A5034

    4-Aminosalicylic Sodium Dihydrate

    Dihydrofolate reductase inhibitor.
    ≥98%
  • K0023

    K252c

    Staurosporine analog; PKC and PKA inhibitor.
    ≥98%
  • F1652

    Fenbufen

    NSAID; COX-1/2 inhibitor.
    ≥98%
  • G0175

    Gastric Inhibitory Peptide, human

    Endogenous peptide hormone, somatostatin analog; G...
    ≥95%
  • K0021

    K252a

    Staurosporine analog; PKC inhibitor, TrkA/B antago...
    ≥98%
  • N1985

    Neuropeptide K, pig

    Endogenous peptide, N-terminal-extended neurokinin...
    ≥95%
  • A4577

    Alsterpaullone

    GSK-3 and CDK inhibitor.
    ≥98%
  • D3372

    Disodium Cycloheptylaminomethylene Diphosphate

    Bisphosphonate; squalene synthase inhibitor.
    ≥98%
  • B6957

    Bromhexine Hydrochloride

    Synthetic derivative of vasicine, mucolytic.
    ≥98%
  • I5752

    Ionomycin, Free Acid

    Polyether Ca2+ ionophore.
    ≥98%, TLC, HPLC
  • C0270

    Carbamazepine

    GABA potentiator, voltage-gated Na+ and ATP-sensit...
    ≥98%
  • O9458

    Oxolinic Acid

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%
  • V9202

    VX-702

    p38 MAPK inhibitor.
    ≥98%
  • B5610

    Boc-PRR-AMC

    Peptide, protease substrate.
    ≥98%
  • S1343

    Ac-SDKP

    Peptide, degradation product of thymosin B4, invol...
    ≥95%
  • T3585

    Tivozanib

    VEGFR1/2/3, c-Kit, PDGFR inhibitor.
    ≥98%
  • J0001

    J-147

    Phenyl hydrazide; neuronal oxidative stress inhibi...
    ≥98%
  • T1024

    Baccatin VI

    Baccatin VI is an impurity of the chemotherapy dru...
    ≥98%